A Search Service for Abbreviation / Long Form

■ 検索結果 - 略語 : tPA

検索条件:
検索語 : tPA
検索方法 : 完全一致
主な研究分野:

結果:  
該当略語: 2
(何れかを選択して該当結果を表示)

(出現頻度降順)
略語: tPA
出現頻度: 8640
対応する展開形の数: 31

表示設定:
[1ページの件数]
ページ移動
/ ページ
展開形 No. 展開形 主な研究分野 共起略語 PubMed/MEDLINE情報 (発表年, 題目)
tissue plasminogen activator
(血栓溶解薬として用いる) 組織プラスミノーゲンアクチベーター, 組織プラスミノゲンアクチベーター, 組織プラスミノーゲン活性化因子
(8377 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1947 回)
PAI-1 (1514 回)
uPA (622 回)
PAI (346 回)
1978 Inhibition of plasminogen activator production in organ cultures by cycloheximide.
tissue-type PA
(169 回)
Biochemistry
生化学, 生物化学
(20 回)
uPA (102 回)
PA (93 回)
PAs (49 回)
1985 Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages.
tissue PA
(25 回)
Neoplasms
新生物, 腫瘍
(4 回)
uPA (15 回)
PA (13 回)
PAs (8 回)
1984 Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.
trans-parinaric acid
(13 回)
Colloids

(6 回)
DPH (6 回)
POPC (5 回)
DPPC (3 回)
1986 Endotoxin protects against hyperoxic decrease in membrane fluidity in endothelial cells but not in fibroblasts.
tissue plasminogen
(9 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(3 回)
HDL-C (3 回)
PAI-1 (3 回)
TC (2 回)
1992 The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review.
tissue Plg activator
(8 回)
Biochemistry
生化学, 生物化学
(3 回)
Pg (3 回)
PLG (3 回)
uPA (3 回)
1992 Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
therapy
((俗)) 精神療法, セラピー, 治療, 治療法, 療法
(6 回)
Medicine
医学, 医薬
(2 回)
PTCA (2 回)
AMI (1 回)
CABG (1 回)
1990 Implications of the TIMI Trials.
trans-palmitoleic acid
(4 回)
Medicine
医学, 医薬
(1 回)
TVA (3 回)
EA (2 回)
cPA (1 回)
2017 Trans Fatty Acids Suppress TNF-alpha-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells.
parameters-tissue plasminogen activator
(2 回)
Transplantation
移植, 移植術
(1 回)
CAD (1 回)
hsCRP (1 回)
ICAM (1 回)
2008 Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.
10  tissue plasminogen activator signal peptide
(2 回)
Medicine
医学, 医薬
(1 回)
ECF (1 回)
ITM (1 回)
2011 DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.
11  tissue recombinant plasminogen activator
遺伝子組み換え型組織プラスミノーゲンアクチベーター
(2 回)
Neurology
神経学, 神経内科学
(2 回)
--- 2007 Sonothrombolysis: experimental evidence.
12  treated with intravenous alteplase
(2 回)
Neurology
神経学, 神経内科学
(2 回)
BAO (1 回)
NSPP (1 回)
sICH (1 回)
2011 Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis.
13  TTPeak
(2 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
rFVIIa (1 回)
2011 Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.
14  types of plasminogen activators, tissue type
(2 回)
Endocrinology
内分泌学
(1 回)
uPA (2 回)
PAI-1 (1 回)
1993 The plasminogen activator and inhibitor system in bone remodelling.
15  components, plasminogen activator
(1 回)
General Surgery
外科学
(1 回)
CM (1 回)
EC (1 回)
HUV (1 回)
1993 Ambient oxygen tension modulates endothelial fibrinolysis.
16  dofetilide, patient-controlled analgesia pump, and alteplase
(1 回)
GSE (1 回)
PACE (1 回)
PSE (1 回)
2019 Evaluation of a Hospital Pharmacist Annual Competency Program.
17  long-term functional outcome for patients who receive intravenous alteplase
(1 回)
Health Services
公共医療
(1 回)
DTN (1 回)
mRS (1 回)
MUSC (1 回)
2018 Long-Term Functional Outcome of Telestroke Patients Treated Under Drip-and-Stay Paradigm Compared with Patients Treated in a Comprehensive Stroke Center: A Single Center Experience.
18  tert-pentyl acrylamide
(1 回)
Chemistry Techniques, Analytical
分析化学法
(1 回)
LB (1 回)
2008 Molecular orientation of azobenzene chromophores in ultrathin polymer nanosheets studied by attenuated total reflection spectroscopy.
19  therapeutic
治療, 治療上, 治療学, 治療学的, 治療的, 療法
(1 回)
Biology
生物学
(1 回)
MCA (1 回)
2011 Modeling stroke in mice - middle cerebral artery occlusion with the filament model.
20  therapy was unavailability of alteplase
(1 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
--- 2017 Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke.
21  therapy with alteplase
(1 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
--- 2015 Endovascular thrombolysis to salvage central venous access in children with catheter-associated upper extremity deep vein thrombosis: technique and initial results.
22  thrombin inhibition by PAI-1 2.5-fold and of thrombin-VR1
(1 回)
Molecular Biology
分子生物学
(1 回)
PAI-1 (1 回)
1999 The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
23  thrombolysis with alteplase
(1 回)
Neurology
神経学, 神経内科学
(1 回)
DWI (1 回)
FLAIR (1 回)
MRI (1 回)
2012 [EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke].
24  thrombolytic activity of alteplase
(1 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
--- 2022 Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis.
25  Tissue plasminogen inhibitor
(1 回)
Hematology
血液学
(1 回)
CRP (1 回)
ERalpha (1 回)
ERbeta (1 回)
2010 Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens.
26  total PA, and tissue PA
(1 回)
Reproductive Medicine
生殖医学
(1 回)
PA (1 回)
uPA (1 回)
2004 [How chronic prostatitis affects plasminogen activator system].
27  transfected with pSVtPA
(1 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
UK (1 回)
1993 High-level expression of antibody-plasminogen activator fusion proteins in hybridoma cells.
28  transfected with these constructs, pSVtPA
(1 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
UK (1 回)
1993 High-level expression of antibody-plasminogen activator fusion proteins in hybridoma cells.
29  treatment and cost of administration of alteplase
(1 回)
Vascular Diseases
血管病, 血管疾患, 血管性疾患
(1 回)
MI (1 回)
r-PA (1 回)
2000 Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA.
30  treatment for ischemic stroke is intravenous administration of plasminogen activator
(1 回)
Medicine
医学, 医薬
(1 回)
--- 2013 Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation.
31  trials of alteplase
(1 回)
Medicine
医学, 医薬
(1 回)
--- 2016 Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis.